Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Cash from Investing Activities (2019 - 2025)

Korro Bio (KRRO) has disclosed Cash from Investing Activities for 6 consecutive years, with $7.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities rose 160.39% year-over-year to $7.6 million, compared with a TTM value of $26.3 million through Sep 2025, up 121.53%, and an annual FY2024 reading of -$123.3 million, down 1204.86% over the prior year.
  • Cash from Investing Activities was $7.6 million for Q3 2025 at Korro Bio, up from -$11.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $32.8 million in Q1 2025 and bottomed at -$102.4 million in Q2 2024.
  • Average Cash from Investing Activities over 5 years is -$7.3 million, with a median of -$3.4 million recorded in 2023.
  • The sharpest move saw Cash from Investing Activities plummeted 2892.2% in 2024, then surged 684.23% in 2025.
  • Year by year, Cash from Investing Activities stood at -$14.6 million in 2021, then soared by 130.63% to $4.5 million in 2022, then tumbled by 136.88% to -$1.7 million in 2023, then plummeted by 67.07% to -$2.8 million in 2024, then soared by 374.72% to $7.6 million in 2025.
  • Business Quant data shows Cash from Investing Activities for KRRO at $7.6 million in Q3 2025, -$11.3 million in Q2 2025, and $32.8 million in Q1 2025.